Latest News - IQVIA
Top Corporates Hub
IQVIA
IQV Q3 Deep Dive: Clinical Research Demand and AI Initiatives Drive Steady Growth
29.10.2025 05:31
Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s revenue to be around $16.2 billion, close to analysts’ estimates. Its non-GAAP profit of $3 per share was 0.8% above analysts’ consensus estimates.
IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say
29.10.2025 00:00
While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript
28.10.2025 13:52
IQVIA Holdings Inc. (NYSE:IQV) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDTCompany ParticipantsKerri Joseph - SVP of Investment Relation &...
IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates
28.10.2025 12:15
IQVIA (IQV) delivered earnings and revenue surprises of +1.35% and +0.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
IQVIA (NYSE:IQV) Beats Q3 Sales Expectations
28.10.2025 11:28
Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 5.2% year on year to $4.1 billion. The company expects the full year’s revenue to be around $16.2 billion, close to analysts’ estimates. Its non-GAAP profit of $3 per share was 0.8% above analysts’ consensus estimates.
IQVIA: Q3 Earnings Snapshot
28.10.2025 11:14
The Durham, North Carolina-based company said it had net income of $1.93 per share. Earnings, adjusted for one-time gains and costs, came to $3 per share. The results surpassed Wall Street expectations.
IQVIA Holdings Inc. 2025 Q3 - Results - Earnings Call Presentation
28.10.2025 11:01
2025-10-28. The following slide deck was published by IQVIA Holdings Inc.
IQVIA Reports Third-Quarter 2025 Results
28.10.2025 11:00
RESEARCH TRIANGLE PARK, N.C., October 28, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2025.
IQVIA (IQV) Reports Earnings Tomorrow: What To Expect
27.10.2025 03:08
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday morning. Here’s what investors should know.
IXJ: Healthcare Sector Dashboard For October
20.10.2025 10:19
Healthcare providers and pharmaceuticals/biotechnology subsectors are undervalued versus 11-year averages, with pharma/biotech also showing strong quality metrics. Read the full analysis.
What to Expect From IQVIA Holdings’ Next Quarterly Earnings Report
15.10.2025 08:25
IQVIA Holdings is gearing up to release its third-quarter earnings later this month, and analysts project a steady single-digit increase in profitability.
3 Reasons to Sell IQV and 1 Stock to Buy Instead
10.10.2025 04:00
IQVIA has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.8%. The stock now trades at $200.20, marking a 39.8% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Is Veeva's Vault CRM Emerging as the Standard for Top Biopharma?
01.10.2025 14:10
VEEV's Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the industry's commercial standard.
IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships
16.09.2025 13:00
RESEARCH TRIANGLE PARK, N.C., September 16, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborative partnerships with clinical trial sites worldwide.
IQVIA: A Positive Long-Term Outlook Despite Trump Legislation
11.09.2025 02:00
Read here for an update on CRO market growth trends, TAS segment performance, and IQVIA (IQV) stock's outlook amid macroeconomic uncertainty.
Can IQVIA Holdings Inc.'s (NYSE:IQV) ROE Continue To Surpass The Industry Average?
08.09.2025 13:00
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...